1. The Genomic Organization of the LILR Region Remained Largely Conserved Throughout Primate Evolution: Implications for Health And Disease
   Lisanne Storm et al, 2021, Frontiers in Immunology CrossRef
2. Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer
   Qian-Qian Wang et al, 2023, World Journal of Gastroenterology CrossRef
3. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
   Qiong-Yuan Chen et al, 2021, Frontiers in Immunology CrossRef
4. Effects of hsa-mir-145-5p on the Regulation of msln Expression in Colorectal Adenocarcinoma
   Junhua Li et al, 2022, Analytical Cellular Pathology CrossRef
5. Prognostic and Clinicopathological Value of Human Leukocyte Antigen G in Gastrointestinal Cancers: A Meta-Analysis
   Yongjia Peng et al, 2021, Frontiers in Oncology CrossRef
6. HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance
   Baimei Zhuang et al, 2021, Frontiers in Immunology CrossRef
7. Combined Identification of Novel Markers for Diagnosis and Prognostic of Classic Hodgkin Lymphoma
   Zhixing Kuang et al, 2021, International Journal of General Medicine CrossRef
8. Comprehensive analysis of LILR family genes expression and tumour‐infiltrating immune cells in early‐stage pancreatic ductal adenocarcinoma
   Qiang Gao et al, 2023, IET Systems Biology CrossRef
9. A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome
   Ricky B. van de Water et al, 2021, International Journal of Molecular Sciences CrossRef
10. HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
    Peilong Li et al, 2021, Frontiers in Immunology CrossRef
11. HLA-G: A New Immune Checkpoint in Cancer?
    Daniëlle Krijgsman et al, 2020, International Journal of Molecular Sciences CrossRef
12. Human leukocyte immunoglobulin-like receptors in health and disease
    Silvia Redondo-García et al, 2023, Frontiers in Immunology CrossRef
13. ILT4 reprograms glucose metabolism to promote tumor progression in triple-negative breast cancer
    Haiqin Zhang et al, 2023, Journal of Cell Science CrossRef
14. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers
    Hui-Hui Xu et al, 2021, Frontiers in Immunology CrossRef
15. ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression
    Zijiang Yang et al, 2021, OncoTargets and Therapy CrossRef
16. HLA-G 14bp Ins/Del Polymorphism, Plasma Level of Soluble HLA-G, and Association with IL-6/IL-10 Ratio and Survival of Glioma Patients
    Maria Bucova et al, 2022, Diagnostics CrossRef
17. Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer
    Qiong-Yuan Chen et al, 2022, International Immunopharmacology CrossRef
18. The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
    Jiji V. D. Attia et al, 2020, International Journal of Molecular Sciences CrossRef
19. Serum Level of Soluble Human Leukocyte Antigen G in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
    Mandana khodashahi et al, 2023, Current Rheumatology Reviews CrossRef
20. The Role of Leukocyte Immunoglobulin-Like Receptors Focusing on the Therapeutic Implications of the Subfamily B2
    Feng Feng et al, 2022, Current Drug Targets CrossRef
21. HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
    Aifen Lin et al, 2021, Frontiers in Immunology CrossRef